Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernest Choy

Showing results (81-90 of 168) with videos related to

Pageof 17
Sort By:
RMD Open|May 7, 2026
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysisAndriko Palmowski, Tobias Haugegaard, Ingiäld Hafström, et al.
Journal of Comparative Effectiveness Research|February 27, 2019
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritisVibeke Strand, Iain McInnes, Philip Mease, et al.
The Journal of Rheumatology|October 17, 2007
The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomesAdam Hutchings, Michael Calloway, Ernest Choy, et al.
Journal of Clinical Medicine|July 14, 2023
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib ExperiencePeter C Taylor, Cedric Laedermann, Rieke Alten, et al.
Rheumatology (Oxford, England)|November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation studyAatke van der Maas, Elisabeth Lie, Robin Christensen, et al.
Rheumatology and Therapy|November 13, 2023
Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE RegistryJeffrey R Curtis, Huifeng Yun, Lang Chen, et al.
BMC Rheumatology|February 4, 2021
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational studyErnest Choy, Lara Groves, Daniel Sugrue, et al.
Rheumatology and Therapy|June 22, 2023
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE RegistryJeffrey R Curtis, Huifeng Yun, Lang Chen, et al.
The Journal of Rheumatology|July 9, 2008
Drug use and toxicity in psoriatic disease: focus on methotrexateWilliam J Taylor, Eleanor Korendowych, Peter Nash, et al.
Pageof 17

Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
RMD Open|May 7, 2026
Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysisAndriko Palmowski, Tobias Haugegaard, Ingiäld Hafström, et al.
Journal of Comparative Effectiveness Research|February 27, 2019
Matching-adjusted indirect comparison: secukinumab versus infliximab in biologic-naive patients with psoriatic arthritisVibeke Strand, Iain McInnes, Philip Mease, et al.
The Journal of Rheumatology|October 17, 2007
The Longitudinal Examination of Arthritis Pain (LEAP) study: relationships between weekly fluctuations in patient-rated joint pain and other health outcomesAdam Hutchings, Michael Calloway, Ernest Choy, et al.
Journal of Clinical Medicine|July 14, 2023
A JAK Inhibitor for Treatment of Rheumatoid Arthritis: The Baricitinib ExperiencePeter C Taylor, Cedric Laedermann, Rieke Alten, et al.
Rheumatology (Oxford, England)|November 13, 2010
Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: a systematic literature reviewSarah L Westlake, Alexandra N Colebatch, Janis Baird, et al.
Annals of the Rheumatic Diseases|November 27, 2012
Construct and criterion validity of several proposed DAS28-based rheumatoid arthritis flare criteria: an OMERACT cohort validation studyAatke van der Maas, Elisabeth Lie, Robin Christensen, et al.
Rheumatology and Therapy|November 13, 2023
Correction: Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE RegistryJeffrey R Curtis, Huifeng Yun, Lang Chen, et al.
BMC Rheumatology|February 4, 2021
Outcomes in rheumatoid arthritis patients treated with abatacept: a UK multi-centre observational studyErnest Choy, Lara Groves, Daniel Sugrue, et al.
Rheumatology and Therapy|June 22, 2023
Real-World Sarilumab Use and Rule Testing to Predict Treatment Response in Patients with Rheumatoid Arthritis: Findings from the RISE RegistryJeffrey R Curtis, Huifeng Yun, Lang Chen, et al.
The Journal of Rheumatology|July 9, 2008
Drug use and toxicity in psoriatic disease: focus on methotrexateWilliam J Taylor, Eleanor Korendowych, Peter Nash, et al.
Pageof 17